Diffusion Pharmaceuticals Inc. Soared
Wed, Apr 01, 2020 at 05:30 PM
Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ) shot up at $0.51, a gain of 61.1%. On Tue 31 Mar 20, DFFN:NASDAQ hit a New 2-Week Intraday High of $0.34. The stock appeared on our News Catalysts scanner on Wed 01 Apr 20 at 08:50 AM in the 'MISCELLANEOUS' category. From Tue 17 Mar 20, the stock recorded 30.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ)
Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy.
Top 10 Gainers:
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 61.09%
- InflaRx N.V. (IFRX:NASDAQ), 50%
- Dynatronics Corporation (DYNT:NASDAQ), 48.2%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 43.41%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 42.38%
- Chembio Diagnostics, Inc. (CEMI:NASDAQ), 39.84%
- Citius Pharmaceuticals, Inc. (CTXR:NASDAQ), 36.64%
- Boxlight Corporation (BOXL:NASDAQ), 35.46%
- Safe-T Group Ltd (SFET:NASDAQ), 32.93%
- Athersys, Inc. (ATHX:NASDAQ), 32.67%